169 related articles for article (PubMed ID: 37138315)
1. Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing.
Lau BT; Almeda A; Schauer M; McNamara M; Bai X; Meng Q; Partha M; Grimes SM; Lee H; Heestand GM; Ji HP
Genome Med; 2023 May; 15(1):33. PubMed ID: 37138315
[TBL] [Abstract][Full Text] [Related]
2. Nanopore sequencing reveals methylation changes associated with obesity in circulating cell-free DNA from Göttingen Minipigs.
Drag MH; Debes KP; Franck CS; Flethøj M; Lyhne MK; Møller JE; Ludvigsen TP; Jespersen T; Olsen LH; Kilpeläinen TO
Epigenetics; 2023 Dec; 18(1):2199374. PubMed ID: 37032646
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma.
Yu SCY; Deng J; Qiao R; Cheng SH; Peng W; Lau SL; Choy LYL; Leung TY; Wong J; Wong VW; Wong GLH; Jiang P; Chiu RWK; Chan KCA; Lo YMD
Clin Chem; 2023 Feb; 69(2):168-179. PubMed ID: 36322427
[TBL] [Abstract][Full Text] [Related]
4. Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients.
Martignano F; Munagala U; Crucitta S; Mingrino A; Semeraro R; Del Re M; Petrini I; Magi A; Conticello SG
Mol Cancer; 2021 Feb; 20(1):32. PubMed ID: 33579306
[TBL] [Abstract][Full Text] [Related]
5. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
van der Pol Y; Tantyo NA; Evander N; Hentschel AE; Wever BM; Ramaker J; Bootsma S; Fransen MF; Lenos KJ; Vermeulen L; Schneiders FL; Bahce I; Nieuwenhuijzen JA; Steenbergen RD; Pegtel DM; Moldovan N; Mouliere F
EMBO Mol Med; 2023 Dec; 15(12):e17282. PubMed ID: 37942753
[TBL] [Abstract][Full Text] [Related]
6. Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing.
Katsman E; Orlanski S; Martignano F; Fox-Fisher I; Shemer R; Dor Y; Zick A; Eden A; Petrini I; Conticello SG; Berman BP
Genome Biol; 2022 Jul; 23(1):158. PubMed ID: 35841107
[TBL] [Abstract][Full Text] [Related]
7. Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid.
Afflerbach AK; Rohrandt C; Brändl B; Sönksen M; Hench J; Frank S; Börnigen D; Alawi M; Mynarek M; Winkler B; Ricklefs F; Synowitz M; Dührsen L; Rutkowski S; Wefers AK; Müller FJ; Schoof M; Schüller U
Clin Chem; 2024 Jan; 70(1):250-260. PubMed ID: 37624932
[TBL] [Abstract][Full Text] [Related]
8. Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients.
Choy LYL; Peng W; Jiang P; Cheng SH; Yu SCY; Shang H; Olivia Tse OY; Wong J; Wong VWS; Wong GLH; Lam WKJ; Chan SL; Chiu RWK; Chan KCA; Lo YMD
Clin Chem; 2022 Sep; 68(9):1151-1163. PubMed ID: 35587130
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
[TBL] [Abstract][Full Text] [Related]
10. Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.
Deng Z; Ji Y; Han B; Tan Z; Ren Y; Gao J; Chen N; Ma C; Zhang Y; Yao Y; Lu H; Huang H; Xu M; Chen L; Zheng L; Gu J; Xiong D; Zhao J; Gu J; Chen Z; Wang K
Genome Med; 2023 Nov; 15(1):93. PubMed ID: 37936230
[TBL] [Abstract][Full Text] [Related]
11. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
12. Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification.
Liu L; Toung JM; Jassowicz AF; Vijayaraghavan R; Kang H; Zhang R; Kruglyak KM; Huang HJ; Hinoue T; Shen H; Salathia NS; Hong DS; Naing A; Subbiah V; Piha-Paul SA; Bibikova M; Granger G; Barnes B; Shen R; Gutekunst K; Fu S; Tsimberidou AM; Lu C; Eng C; Moulder SL; Kopetz ES; Amaria RN; Meric-Bernstam F; Laird PW; Fan JB; Janku F
Ann Oncol; 2018 Jun; 29(6):1445-1453. PubMed ID: 29635542
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genome-wide in cell free DNA methylation: progress and prospect.
Liu Z; Wang Z; Jia E; Ouyang T; Pan M; Lu J; Ge Q; Bai Y
Analyst; 2019 Oct; 144(20):5912-5922. PubMed ID: 31436778
[TBL] [Abstract][Full Text] [Related]
14. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
Zeng H; He B; Yi C; Peng J
J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
[TBL] [Abstract][Full Text] [Related]
15. Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers.
Miller BF; Pisanic Ii TR; Margolin G; Petrykowska HM; Athamanolap P; Goncearenco A; Osei-Tutu A; Annunziata CM; Wang TH; Elnitski L
Clin Epigenetics; 2020 Oct; 12(1):154. PubMed ID: 33081832
[TBL] [Abstract][Full Text] [Related]
16. DISMIR: Deep learning-based noninvasive cancer detection by integrating DNA sequence and methylation information of individual cell-free DNA reads.
Li J; Wei L; Zhang X; Zhang W; Wang H; Zhong B; Xie Z; Lv H; Wang X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34245239
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic tumor heterogeneity in the era of single-cell profiling with nanopore sequencing.
Ahmed YW; Alemu BA; Bekele SA; Gizaw ST; Zerihun MF; Wabalo EK; Teklemariam MD; Mihrete TK; Hanurry EY; Amogne TG; Gebrehiwot AD; Berga TN; Haile EA; Edo DO; Alemu BD
Clin Epigenetics; 2022 Aug; 14(1):107. PubMed ID: 36030244
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation-calling tools for Oxford Nanopore sequencing: a survey and human epigenome-wide evaluation.
Liu Y; Rosikiewicz W; Pan Z; Jillette N; Wang P; Taghbalout A; Foox J; Mason C; Carroll M; Cheng A; Li S
Genome Biol; 2021 Oct; 22(1):295. PubMed ID: 34663425
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]